PATIENT-REPORTED AND QUALITY OF LIFE OUTCOMES FROM MYCARING, A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL OF ROZANOLIXIZUMAB IN GENERALISED MYASTHENIA GRAVIS

被引：0
|
作者：
Habib, Ali A. [1 ]
Druzdz, Artur [2 ]
Grosskreutz, Julian [3 ]
Kaminski, Henry [4 ]
Mantegazza, Renato [5 ]
Sacconi, Sabrina [6 ]
Utsugisawa, Kimiaki [7 ]
Vissing, John [8 ]
Vu, Tuan [9 ]
Morel, Thomas [10 ]
Boehnlein, Marion [11 ]
Woltering, Franz [11 ]
Bozorg, Ali [12 ]
Gayfieva, Maryam [13 ]
Bril, Vera [14 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] Municipal Hosp Poznan, Poznan, Poland
[3] Univ Lubeck, Lubeck, Germany
[4] George Washington Univ, Med Ctr, Washington, DC 20037 USA
[5] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[6] CHU Nice, Nice, France
[7] Hanamaki Gen Hosp, Hanamaki, Japan
[8] Univ Copenhagen, Rigshosp, Copenhagen, Denmark
[9] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA
[10] UCB Pharma, Brussels, Belgium
[11] UCB Pharma, Monheim, Germany
[12] UCB Pharma, Morrisville, NC USA
[13] UCB Pharma, Slough, Berks, England
[14] Univ Hlth Network, Toronto, ON, Canada
来源：
MUSCLE & NERVE | 2022年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [31] Patient-reported outcomes from a phase HI multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing alter chemotherapy: Cancer Oesophagus Gefitinib (COG)
    Dutton, Susan J.
    Blazeby, Jane M.
    Petty, Russell D.
    Mansoor, Wasat
    Thompson, Joyce
    Harrison, Mark
    Abbas, Haider
    Dahle-Smith, Asa
    Chatterjee, Anirban
    Falk, Stephen
    Garcia-Alonso, Angel
    Fyfe, David Walter
    Hubner, Richard
    Gamble, Tina
    Peachey, Lynnda
    Harvey, Christine
    Julier, Patrick
    Jankowski, Janusz
    Midgley, Rachel
    Ferry, David R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [32] Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
    Anca D. Askanase
    George J. Wan
    Mary P. Panaccio
    Enxu Zhao
    Julie Zhu
    Roman Bilyk
    Richard A. Furie
    [J]. Rheumatology and Therapy, 2021, 8 : 573 - 584
  • [33] Patient-reported outcomes in the phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis
    de Seze, J.
    Montalban, X.
    McDougall, F.
    Sauter, A.
    Deol-Bhullar, G.
    Wolinsky, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 677 - 678
  • [34] Patient-reported outcomes in the phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis
    de Seze, Jerome
    Montalban, Xavier
    McDougall, Fiona
    Julian, Laura
    Sauter, Annette
    Deol-Bhullar, Gurpreet
    Wolinsky, Jerry
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 84 - 84
  • [35] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO DETERMINE THE EFFICACY OF CYCLOSPORINE-A IN THE TREATMENT OF MYASTHENIA-GRAVIS
    TINDALL, RSA
    ROLLINS, JR
    PHILLIPS, JT
    GREENLEE, RG
    BELENDIUK, G
    [J]. NEUROLOGY, 1986, 36 (04) : 196 - 197
  • [36] Patient-Reported Outcomes from the ARISE Trial: A Phase 3, Randomized, Double-Blind Study of Erenumab in Subjects with Episodic Migraine
    Ashina, M.
    Brandes, J. L.
    Katsarava, Z.
    Lipton, R. B.
    Pascual, J.
    Palmer, K.
    Desai, P.
    Picard, H.
    Mikol, D. D.
    Lenz, R. A.
    [J]. HEADACHE, 2017, 57 : 192 - 192
  • [37] Patient-Reported Outcomes from the STRIVE Trial: A Phase 3, Randomized, Double-Blind Study of Erenumab in Subjects with Episodic Migraine
    Buse, D. C.
    Lipton, R. B.
    Hallstrom, Y.
    Reuter, U.
    Tepper, S. J.
    Zhang, F.
    Sapra, S.
    Picard, H.
    Mikol, D. D.
    Lenz, R. A.
    [J]. HEADACHE, 2017, 57 : 198 - 199
  • [38] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    [J]. CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [39] The short-term impact of methylprednisolone on patient-reported sleep in patients with advanced cancer in a randomized, placebo-controlled, double-blind trial
    Jakobsen, Gunnhild
    Engstrom, Morten
    Hjermstad, Marianne Jensen
    Rosland, Jan Henrik
    Aass, Nina
    Albert, Eva
    Kaasa, Stein
    Fayers, Peter
    Klepstad, Pal
    Paulsen, Ornulf
    [J]. SUPPORTIVE CARE IN CANCER, 2021, 29 (04) : 2047 - 2055
  • [40] 3,4-diaminopyridine in childhood myasthenia: Double-blind, placebo-controlled trial
    Anlar, B
    Varli, K
    Ozdirim, E
    Ertan, M
    [J]. JOURNAL OF CHILD NEUROLOGY, 1996, 11 (06) : 458 - 461
12345